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Abstract 
AN INVESTIGATION OF CENTRAL NERVOUS SYSTEM CONDUCTION PROPERTIES IN 
DIABETES MELLITUS USING BRAINSTEM AUDITORY AND SOMATOSENSORY EVOKED 
POTENTIALS 
Randy L, Anderson 
Department of Psychology Virginia Commonwealth University, 1981 
Major Director: Dr. Joseph H. Porter 
In this study brainstem auditory evoked potentials (BAEPs), median 
nerve conduction velocities (CV) and early somatosensory evoked poten-
tials (SEPs), were employed as indices of neural conduction properties 
in a group of young insulin dependent diabetics (five males and five 
females) and a group of nondiabetic controls (five males and five fe-
males). The median nerve CV was determined from 64 summated nerve res-
ponses recorded at the elbow, The nerve was stimulated at the wrist 
using 0,2 msec square wave electrical pulses, The SEP was recorded from 
scalp electrodes using the same median nerve stimulation technique as 
for the CV measure, The BAEPs were produced by recording responses to 
7 0 dB SL clicks delivered to the right ear at a rate of 10 per second, 
Measures of central transmission time were determined from each of the 
EP modalities, The time interval between BAEP waves I and V determined 
the BAEP CTT. SEP waves P9 to Pl4 determined the earliest SEP CTT 
measure. 
Comparisons between the two diagnostic groups yielded the following 
results: The diabetic group evidenced a significant (p = 0, 02) slowing 
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of the median nerve, 53 meters per second for the diabetic group versus 
59 meters per second for the nondiabetic group, With height covaried out, 
only the SEP Pl4 latency showed a significant diagnostic group difference. 
More interesting were the findings for the principal SEP CTT measure. 
The diabetic group had significantly (p � 0.01) longer CTTs from P9 to 
Pl4, 5.0 msec as opposed to 4,2 msec for the nondiabetic group. The 
diabetic group also had significantly (p = 0.03) longer CTTs for the 
BAEP, 4.2 msec versus 4.0 msec for the nondiabetic group. Although the 
magnitude of the diagnostic group differences are small, the median 
nerve CV, SEP CTT, and BAEP CTT measures indicate that diabetic neuro­
pathy is pervasive, occurring centrally, as well as peripherally, as 
early as young adulthood in juvenile onset, insulin dependent diabetics, 
Introduction 
A number of studies have documented abnormal peripheral conduction 
velocity in persons with diabetes mellitus (Horowitz & Ginsberg-Fellner, 
1979; Noel, 1973; Oester, Zalis, & Radriquez, 1972; Gregerson, 1967). 
Diabetic neuropathy is known to affect both sensory and motor nerves, 
producing abnormalities ranging from muscle paralysis to asymptomatic 
neurophysiological abnormalities such as reduced conduction velocity 
(Porte, Graf, Halter, Pfeifer, & Halar, 1981; Ward, Fisher, Barnes, Jessop, 
& Baker, 1971). In contrast, there is little information available re­
garding the effects of diabetes on the central nervous system (CNS). 
The available information comes predominantly from postmortem identifi­
cation of intracranial anatomical alterations in diabetes (DeJong, 1977). 
In many of these cases, death resulted from pathology unrelated to dia­
betes. In the cases studied where death was related to diabetes, there 
were multiple, possibly confounding complications involving other organ 
systems. This information gap is partly due to the relative difficulty 
of measuring CNS function. 
This project is an attempt to determine if metabolic abnormalities 
inherent in diabetes might affect CNS function as well as peripheral 
nervous system function. The success of scalp recorded evoked potentials 
in other applications suggests that they should provide accurate informa­
tion about changes in function of the central nervous system as a result 
of diabetic neuropathy. 
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Brainstem evoked potentials (EPs) are electrical manifestations of 
the brainstem, in the nanovolt range, occurring in response to discrete 
stimulation of one of the sensory modalities. The EP electrical energy 
is volume conducted from the brainstem nuclei of origin, up through the 
brain mass to the scalp where it may be detected using scalp electrodes. 
Since the EPs occur on the background of ongoing EEG activity that is in 
the microvolt range, it is necessary to summate EP responses from many 
stimulus presentations in order to visualize the response. With serial 
summation, theoretically random background EEG activity (noise) tends to 
subtract out, while the stimulus response (signal) that is temporally 
locked to the stimulus presentation, adds up. In short, the summation 
process makes the EP response more prominent by improving the signal to 
noise ratio. 
In this study, brainstem auditory evoked potentials (BAEPs) and 
early somatosensory evoked potentials (SEPs) were recorded as indices of 
CNS brainstem function in previously diagnosed young adult insulin depen­
dent diabetics. The BAEPs were recorded in response to brief click sti­
muli. The SEPs were recorded in response to median nerve stimulation at 
the wrist. 
Two previous studies have been reported in which the SEP was used 
as a measure of diabetic neuropathy (Noel, 1973; Oester � �., 1972). 
However, it was used only as an index of peripheral conduction from the 
site of stimulation up to wave Nl8 of the SEP (see Fig. 1, middle trace). 
In this research, an attempt has been made to use the SEP as a measure 
of both central and peripheral neuropathy. 
The BAEP has proven to be an excellent comparative measure of CNS 
neuropathy since its peripheral component, wave I, is easily delineated 
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from the central components (Starr, 1978; Starr & Achor, 1979; Salamy & 
McKean, 1976; Salamy, McKean, & Buda, 1975). The integrity of the audi­
tory receptor organ is verified in each participant using pure tone 
audiometry. Thus, differences in BAEP components are attributable to 
the neural pathways. Apparently, no other studies have been reported 
using the BAEP as a measure of diabetic neuropathy. 

Literature Review 
Brainstem Auditory Evoked Potentials 
Use of the brainstem auditory evoked potential (BAEP) for highly 
specific localized neurologic evaluation is dependent upon determination 
of the neuroanatomical correlates of each waveform. There are four 
methods used to identify neural generators of EP waveforms: depth re­
cording, lesion-making experiments, deductions from clinical cases, and 
potential field analysis. The first two methods are most always limited 
to nonhuman subjects, whereas the latter two yield less specific findings. 
Thus, it is necessary to use results from the first two methods to veri­
fy results of the second two, and vice versa. This process has led to a 
general consensus as to the neural origins of waves I through V of the 
BAEP. 
Wave I arises from the potential volley along the acoustic nerve. 
Wave II arises from the cochlear nuclei (first central synapse in the 
pathway). Wave III arises in the region of the superior olivary com­
plexes, Wave IV arises from tracts and nuclei of the lateral lemniscus. 
Wave V arises at the level of the inferior colliculi (Chiappa, Gladstone, 
& Young, 1979; Fabiani, Sohmer, Tait, Gafni, & Kinarti, 1979; Starr & 
Achor, 1979; Salamy & McKean, 1976; Buchwald & Huang, 1975). 
There is some speculation about the finality of these BAEP origins 
or at least the implied one-to-one correspondence between given peaks 
and neuroanatomical structures. Discrete lesions can affect the amplitudes 
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of several BAEP components with no effect on latency (Starr & Achor, 
1979). Also, isocontour maps show a distribution of potential fields 
6 
throughout the brainstem during the occurrence of wave II (Starr & Achor, 
1979). Thus it appears that several neural generators contribute simul-
taneously to the generation of individual BAEP components, whereas some 
auditory structures do not contribute at all to the generation of the 
BAEP (Starr & Achor, 1979). 
Despite the complexity of neural origin, the BAEP is very stable 
within and between individuals. Further, the prominence of the BAEP 
components makes them fairly easy to score (see Fig. 1, lower trace). 
Typically, the latency of each peak is taken as the point of highest 
amplitude over the peak. Discrepancies sometimes arise due to morpholo-
gical variation in the IV-V complex. The qualitative patterns in appear-
ance of the IV-V complex have been described by Chiappa � �- (1979). 
These patterns are essentially permutations of the combined factors of 
the relative height and presence or absence of the two waves: 
Pattern 
A 
B 
C 
D 
E 
F 
Morphology 
A single peak in the range of V; 
2 peaks; wave IV lower than V; 
2 peaks; IV higher than V; 
IV as a shoulder on V; 
V as a shoulder on IV; 
IV and V equal. 
In this study, wave IV was scored as missing if the BAEP showed the A 
pattern. The BAEP shown in Fig. 1 is representative of Pattern A. Wave 
IV was scored in Pattern D cases only if the slope of an imaginary tan-
gent line to the curve appeared to reach zero over several consecutive 
digital points. 
Table 1 shows representative BAEP latency and amplitude data taken 
from previous publications. One of these studies was designed to examine 
..... Table 1 
Representative Brainstem Auditory Evoked Potential Data 
Publication I II III IV V CTT 
Latencies (msec� 
Salamy & McKean, 1976 1.57 ± 0.14 2.73 ± 0.19 3.64 ± 0.24 4.82 ± 0.23 5.55 ± 0.26 3.99 .± 0.21 
Harkins, McEvoy, & 
Scott, 1978 1.73 .± 0.11 2.84 .± 0.13 3.77+0.11 no report 5.70 ± 0.19 3.97* 
Michalewski, et�., 
1980 (males only) 1.90+0.26 3.02 ± 0.22 3.98 ± 0.28 5.32 .± 0.24 S.96_±0.16 4.06* 
Michalewski, et�., 
1980 (females only) 1.78 .± 0.12 2.96 ± 0,12 3.82 ± 0.16 5.31 .± 0.27 5.79 ± 0.08 4.01* 
Starr, 1977 1.5 2.7 3.8 4.7 s.s 3.8 .± 0.2 
Amelitudes {uV� 
Starr & Achor, 1975 0.28 .± 0,08 0.16 ± 0.09 0.26 ± 0.07 0.11 .± 0.10 0.30 ± 0.06 
Scott & Harkins, 1978 0.24 ± 0.04 0.17 ± 0.05 0.29 _± 0.03 no report a.so± 0.06 
Michalewski, et�., ** 
1980 (males only) 0.31 ± 0.26 0.41 .± 0.22 0.43 .± 0.16 0.80 .± 0.31 1.10 ± 0.34 
Michalewski, et�., ** 
1980 (females only) 0.32 + 0.14 o.so .± 0.18 0.35 .± 0.15 1.17 _± 0.45 1.50 ± 0.42 
* CTT calculated by difference from reported data. 
** Calculated as the difference between wave peak and preceeding negativity. 
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sex differences in the BAEP (Michalewski, Thompson, Patterson, Bowman, & 
Litzelman, 1980). While the females in the Michalewski study tended to 
have shorter latencies for all BAEP components, only the wave v latency 
sex difference was statistically significant (p< 0.05). At least one 
other study had previously reported a sex difference in wave v latency 
(Stockard, Stockard, & Sharbrough, 1978), 
The Michalewski study (1980) also reported significantly larger am­
plitudes for waves IV, V, VI, and VII among their female participants. 
However these findings are presented here only for relative comparison 
between the two sex groups since the Michalewski study calculated ampli­
tudes as the difference between each wave peak and its preceeding negati­
vity. For this study and the other two in Table 1, the amplitude of each 
component was measured from each positive peak to the subsequent 
negativity. 
Several studies have used components of the BAEP to obtain a measure 
of transmission time through a segment of the CNS (Fabiani� al., 1979; 
Starr, 1978; Starr & Achor, 1979; Salamy & McKean, 1976; Salamy��-, 
1975), Such a measure is typically referred to as central transmission 
time (CTT). The most widely used BAEP CTT measure is the time interval 
between the peak of wave I and the peak of wave V. This measure provides 
a neurological evaluation of the brainstem auditory pathway that is 
relatively independent of click intensity and receptor factors (Starr & 
Achor, 1979), 
Peripheral Conduction Velocities 
Abnormalities of peripheral conduction over the primary afferent 
neurons of the specific somatosensory system have a direct influence on 
SEP latencies and amplitudes. Therefore, it is necessary to assess the 
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integrity of the stimulated peripheral nerve in order to use the SEP to 
evaluate putative abnormalities of the central somatosensory system 
(Starr, 1978), This assessment is typically done by recording the peri­
pheral nerve volley over a given segment of the nerve with bipolar elec­
trodes and calculating the conduction velocity in meters per second, 
The nerve volley is evoked using the same stimulus as for the SEP re­
cording, The recorded waveform is a triphasic potential that is ini­
tially positive, then strongly negative, and ending with a slow positive 
component (see Fig, 1, upper trace), The negative phase is produced by 
action potentials passing beneath the recording electrodes, The posi­
tive phases can be obscured if the surface recording location is far 
from the nerve fiber (Cracco, Cracco, & Anziska, 1979). The onset laten­
cy of the negative component is typically used in calculation of median 
nerve conduction velocity (CV) (Desmedt & Cheron, 1980b; Noel, 1973). 
This method measures the CV of the fastest conducting afferent (large 
diameter, myelinated) fibers (Greene, Brown, Braunstein, Schwartz, Asbury, 
& Winegrad, 1981). 
Somatosensory Evoked Potentials 
SEPs are typically elicited with electrical pulses of 0. 1 to 0.5 
msec duration delivered to the skin over the median nerve just proximal 
to the wrist. The electrode arrangement is bipolar with the cathode 2 
to 3 cm proximal to the anode (Desmedt & Cheron, 1980b; Cracco et al., 
1979; Starr, 1978). Stimulus rate is usually 3 to 5 pulses/sec at 50 
volts. Stimulus rate and duration are important in determining the type 
of nerve fiber being stimulated. Faster or longer pulses tend to trigger 
the slower conducting A-delta and C fibers associated with pain sensation 
(Schmidt, 1978) and reduce SEP resolution. Stimulus intensity is less 
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critical since currents lightly ab th h ld 1 ove res o e icit maximal response 
amplitudes (Starr, 1978). SEPs are most frequently recorded from the 
parietal scalp (over somatosensory cortex) with a reference electrode on 
the earlobe, neck, or forehead. A noncephalic reference electrode is 
sometimes pre fer red because of its greater "neutrality" with respect to 
the recording electrode (Desmedt & Cheron, 1980b). However, the 
noncephalic reference is subject to greater myogenic contamination. 
SEPs offer the opportunity to evaluate the function of the entire 
somatosensory system (Cracco � �., 1979). However, the utility of 
the SEP is dependent on precise relationships between neural generators 
and SEP waveforms (Desmedt & Cheron, 1980b; Starr, 1978), Unfortunately, 
these relationships are currently much less precise than those of the 
BAEP. Not only are the neural generators somewhat speculative, but also 
identification of SEP waves is different in existing publications (e.g., 
Starr, 1978 reports a Pl2 but not Pll or Pl3). 
Ignoring the peak latency variations due to variations of armlength, 
the early SEP to median nerve stimulation has three major positive waves 
and one major negative wave within 20 msec of stimulus onset. The first 
positivity is around 9 msec (P9), the second around 11 msec (Pll). The 
third positivity typically has two lobes, one around 13 msec (Pl3) and 
the other around 14 msec (Pl4). A large negativity occurs around 19 
msec (Nl8), usually with small positive waves "riding" on it, Another 
large positive wave follows Nl8 at around 22 msec (P22) (Desmedt & 
Cheron, 1980b; Cracco � �., 1979) (see Fig. 1, middle trace). P22 is 
not seen in several of the taller participants in this study because its 
duration is greater than the post stimulus measurement time of 25 . 5 msec, 
Pl3 has an extremely variable morphology between individuals. It 
may predominate over Pl4 or be altogether missing (see Fig. 2). Pl3 
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and Pl4 can be extremely difficult to differentiate because of the vari­
able morphology of Pl3 and the latency "shifts" introduced by variations 
in armlength across individuals. This interpretation problem is further 
complicated in the presence of neuropathy. The general influence of 
neuropathy is to increase peak latencies and decrease amplitudes, as a 
result of demyelination, fiber loss, and/or decreased metabolic inte­
grity (Cracco � �., 1979; Starr, 1978), Finally, stimulation of the 
median nerve excites some motor axons that may contaminate the SEP. 
Recently, the identification of the SEP waves has been clarified by 
considering " . the conduction distances and anatomical features of 
each of the three neurones making up the central somatosensory pathway 
in adult man, and (attempting) to relate interpeak delays of SEP far­
fields to actual conduction times along these neurones," (Desmedt & 
Cheron, 1980b, p. 394). 
The Desmedt & Cheron (1980b) procedure uses electrical stimulation 
of the index and middle fingers in order to stimulate only sensory fibers. 
The median nerve volley is then recorded at the wrist, the axilla, Erb's 
point, and at the entrance to the spinal ganglion (C6-C7), as well as 
from the scalp. Further, the scalp SEP is recorded with a noncephalic 
reference (on the unstimulated forearm) to substantially reduce pick up 
of the early far fields at the reference electrode. Their results show 
clearly that P9 occurs before the arrival of the nerve volley at Erb's 
point but after its arrival at the axilla. Thus, the P9 wave of the 
scalp recorded SEP establishes that Pll arises from passage of the affe­
rent volley through the ascending dorsal column. The Pll onset 
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corresponds precisely with the arrival of the peripheral nerve volley at 
the spinal cord (Desmedt & Cheron, 1980b). 
After careful consideration of the geometry of the ascending central 
somatosensory pathway, Desmedt & Cheron (1980b) were able to establish 
that the Pl3 and Pl4 generators are below the thalamus but above the 
foramen magnum. It appears that the lemniscal volley has just begun to 
activate the ventro-basal thalamic neurones at Pl4 onset (Desmedt & 
Cheron, 1980b). This conclusion is in agreement with a report by 
Greenberg, Mayer, Becker, & Miller (1977) that this wave has no thalamic 
or cortical component because they have recorded it in five patients with 
electrical and clinical brain death. Desmedt & Cheron (1980b) conclude 
that Nl8 is the response of cortical projection of the afferent volley. 
Thus, the descending (positive up) limb of Nl8 can be used as a marker 
for estimating the cortical SEP latency. Desmedt & Cheron (1980b) 
believe that Nl8 is related to postsynaptic potentials elicited in apical 
dendrites of pyramidal neurones. 
Diabetic Neuropathy 
The term, diabetic polyneuropathy, describes a multiplicity of 
neuronal degenerative anomalies associated with diabetes mellitus. Peri­
pherally, the major manifestation of diabetic neuropathy is reduced con­
duction velocity in sensory and motor nerves. The presence of neuropathy 
in long standing insulin dependent diabetics is not universal (Pirart, 
1978). However histological and electrophysiological evidence suggests 
that the reduced CV is the result of demyelination and subsequent loss 
of nerve fibers (Noel, 1973) beginning well before clinical manifesta­
tions (Greene et al., 1981). The degree of glycemic control and duration 
of diabetes are major determinants of the progression of the degenerative 
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process (Porte� al., 1981; Greene et�., 1981; Horowitz & Ginsberg­
Fellner, 1979; Pirart, 1978; Skyler, Lasky, Skyler, Robertson, & Mintz, 
1978; Ward et al., 1971; Gregerson, 1967). Indeed, careful management 
of blood glucose has been shown to reverse the degenerative process to 
some extent (Ward��., 1971) with the potential reversal probably 
limited by the degree of large fiber loss (Greene��., 1981). 
Diabetic neuropathy sometimes involves weakened neuromuscular trans-
mission mechanisms (Miglietta, 1973), altered pupillary reflexes 
(Hreidarsson, 1981) as well as reduced skin sensitivity to temperature, 
pin prick, proprioception, and vibration (Greene� al., 1981). While 
it is well established that these and other processes affected by diabe-
tes are the result of primary neuronal changes, it is not certain whether 
the central mediation of these processes is affected. Neuromuscular 
transmission mechanisms are affected in some diabetics resulting in a 
decline in muscle action potentials with high stimulation frequency (20-
SO per second) (Miglietta, 1973). The decline in neuromuscular transmis-
sion is observed in some diabetics despite their having normal CVs 
(Miglietta, 1973). Some motor fibers are apparently immune to this de-
crement, such as those serving the fingers (Miglietta, 1973). Abnormali-
ties of pupil unrest are known to occur during hyperglycemia (Hreidarsson, 
1981). Since the control of pupillary unrest is of central origin (see 
Hreidarsson, 1981), it is possible that the abnormalities associated with 
hyperglycemia are directly related to the effects of hyperglycemia on the 
central autonomic nervous system (Hreidarsson, 1981). 
Electroencephalographic studies show a higher incidence in diabetics 
of abnormally slow and abnormally fast waves (DeJong, 1977). These 
abnormalities appear to be associated with recurrent hypoglycemia 
(DeJong, 1977). 
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Gupta and Dorfman (1981) have reported longer spinal conduction 
times in a heterogeneous group of diabetics, but no difference in supra­
spinal (cervical cord to cortex) conduction. They used an indirect 
method of calculating spinal transit time and supraspinal transit time 
(Dorfman, 1977) from the SEP. They suggest that the supraspinal segment 
of the somatosensory pathway is more resistant to diabetic neuropathy. 
In cases of diabetic neuropathy, sensory nerve potentials show re­
duced amplitude, a less well defined shape, and increased latency of 
the initial peak (Noel, 1973). Lesions of the central somatosensory 
pathway are expected to affect the appearance of the SEP in the same 
three ways (Oester � �-, 1972). 
The central purpose of this investigation was to determine, in the 
most direct way possible, if a group of young adult insulin dependent 
diabetics evidence altered neuronal function within the CNS, as measured 
with scalp recorded EPs. 
Methods 
Subjects 
Persons between the ages of 20 and 30 were recruited for participa-
tion in this study using fliers posted around the university campus, 
When potential participants reported to the EP lab, the entire testing 
procedure was explained, followed by an opportunity to ask questions, 
Written consent was then obtained from each participant, All were paid 
$5,00 per hour of participation. Responses to the screening question-
naire were used to exclude individuals who had a potentially confounding 
medical history, The questionnaire identified two such cases, both 
diabetics, The first had diagnosed peripheral neuropathy that had pro-
duced temporary paralysis of the legs, as well as a history of neurologic 
seizures, The second individual was approximately 80 pounds over 
reccxrunended body weight for his height and build, 
After completion of the screening questionnaire, a urine sample was 
collected from each participant, Each sample was tested immediately for 
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presence of glucose and ketones (AMES KETO-DIASTIX), No member of the 
nondiabetic group had previous evidence of diabetes nor did any show 
positive urinalysis results, All diabetics showed presence of urine glu-
cose on either the first urine sample or a second sample taken halfway 
through EP testing (see Table 2). Therefore, these tests verified the 
self-report diagnostic classification of the diabetics. None of the 20 
participants showed urine ketones in either urine sample, 
16 
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...... Table 2 
Urine Glucose Test Results 
DIABETICS: 
Female 
n 
Male 
n 
NONDIABETICS: 
Female 
n 
Male 
First Second 
Urinalysis Urinalysis 
mg/dL mg/dL 
0.07 .± 0.06 1.00 + o. 82 
3 4 
0.75 .± 0.96 0.71 + 0.87 
4 4 
0 N/A 
s 
0 N/A 
s 
18 
An audiogram was completed on each participant to establish hearing 
efficacy. The audiograms were collected in a quiet room using a Beltone 
portable audiometer. None of the 20 participants showed a hearing defi­
cit greater than 30 dB at any of eleven frequency bands between 125 Hz 
and 8000 Hz (see Fig. 3). Furthermore, the two groups did not differ 
significantly over any of the eleven frequency bands, nor did hearing 
threshold to the BAEP click stimulus show a significant group difference. 
One nondiabetic individual was excluded from participation based on the 
audiogram. This individual had hearing thresholds of 45 dB over three 
frequency bands in both ears. 
All ten diabetic participants met the following inclusion criteria: 
1) insulin dependent from first diagnosis; 2) no previously diagnosed 
neuropathy; 3) body weight within ten pounds of ideal for height and 
build (Metropolitan Life Insurance statistics); 4) no history of any 
other metabolic or neurological disease. The diabetic group had a mean 
age fo 23.9 ± 3.4 years (range of 20 to 30 years) and consisted of five 
males and five females. The mean duration since diagnosis was 7.8 + 
5.8 years (range of 2.5 to 1 7 years). The nondiabetic control group 
also had five males and five females. Mean age for this group was 26. 1 
± 3.3 years (range of 20 to 30 years). 
Procedure 
Stimuli for the BAEPs were 70 dB SL condensation phase click sounds 
generated by passing 0.1 msec square wave electrical pulses through TDH-
49 headphones. Stimulation was to the right ear at a rate of ten per 
second. BAEPs were recorded from vertex (Cz) referenced to the right 
t "d w1."th a �round electrode clipped to the rig
ht earlobe mas 01. process, o 
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(Scott & Harkins, 1978; Harkins McEvoy & Scott 1978· p· t H"ll d , , , , ic on, i yar , 
Krausz, & Galambos, 1974). 
Stimuli for the SEPs and the median nerve CV measures were 0.5 msec 
square wave electrical pulses delivered three per second to the left 
median nerve just proximal to the wrist. The cathode was two cm proximal 
to the anode. A ground electrode was placed on the inner surface of the 
forearm midway between the wrist and elbow. Stimulation voltage was 50 
volts. The thumb twitch motor threshold established stimulus intensity 
for each case (Starr, 1978). The stimuli were generated by a Grass S88 
stimulator, a stimulus isolation unit, and a constant current unit 
connected in series. 
SEPs were recorded from a parasagital electrode placed over the con-
tralateral hand representation area of somatosensory cortex (one cm in-
ferior and one cm posterior to C4 of the International 10-20 system of 
cephalic electrode placement). The cephalic electrode was referenced to 
a nuchal electrode between cervical vertebrae five and six (Harkins & 
Dong, 1980). 
The electrophysiological responses being measured were amplified by 
a Grass P511J preamplifier set at a gain of 5 x 104 with filters at 10 
Hz and 3000 Hz. A Nicolet 1074 signal summator was used to process the 
EEG for EPs and to determine the mixed nerve CV to median nerve stimula-
tion. A bin width of 100 usec was employed for collecting the SEPs and 
the CV measures. Bin width was 50 usec for the BAEPs. During summation, 
the EEG was continuously monitored. Processing was stopped when muscle 
or other artifacts were apparent (Chiappa � �., 1979). For both EP 
modalities, four consecutive traces of 1024 stimulus presentations each 
were overlapped to permit determination of response stability. The 
median nerve CV measure was determined from two repeated traces of 64 
stimulus presentations each, Once collected, the EPs were plotted out 
from the signal sununator using an X-Y plotter, The important points 
were designated and the corresponding digital values for latency and 
amplitude of each point were taken from the signal summator memory, 
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The digital values were then entered into VCU's IBM 370 computer, along 
with other data on each participant, for subsequent processing using the 
Statistical Analysis System (SAS).· 
Results 
Separate three-way analyses of variance (diagnosis x sex x diagnosis­
sex interaction) were performed on all dependent variables except those 
of the audiograms and urinalysis results. The analyses of variance were 
performed using the ANOVA procedure of SAS. Correlations were performed 
using the CORR procedure of SAS. In the following account of the results, 
statistically significant differences between the diabetics and nondia-
betics are referred to as diagnostic group differences, whereas statisti-
cally significant differences between females and males are referred to 
as sex group differences. 
As a check for equivalent auditory reception in each diagnostic 
group, the group means for each frequency band of the audiograms were 
compared using t-tests. There was no significant diagnostic group dif-
ference at any of the levels tested (see Fig. 3). The anaLysis of vari-
ance for a difference in click stimulus threshold also showed no diagnos-
tic group significance (see Table 3) (n's may vary throughout all tables 
because of missing values). Thus it appears that any group differences 
in the BAEP measure did not result from an influence of diabetes on the 
auditory receptor. 
There was also no diagnostic group difference in sensory or motor 
threshold to the electrical stimulus, evidencing the absence of any symp-
tomatic deficits in the diabetics (see Table 3). The females as a group 
had significantly lower sensory thresholds than did the males. However, 
motor thresholds showed no significant sex group difference. 
22 
("') 
N 
DIABETICS: 
Female 
n 
Male 
n 
NONDIABETICS: 
Female 
n 
Male 
n 
DIAGNOSIS: 
F 
.E 
SEX: 
F 
.E 
DIAGNOSIS & SEX 
INTERACTION: 
F 
E 
Table 3 
Stimulus Response Parameters, Height and Weight Data 
Click Sensory Motor 
Threshold Threshold Threshold 
(dB) (mA) (mA) Height Weight 
9 + 4 0.5 + 0.05 
5 4 
11 + 4 0.7 ± 0.46 
5 5 
13 + 9 0.4 ± 0. 10 
s 5 
12 + 4 0.8 + 0.25 
5 5 
0.9 0.1 
0.35 o. 79 
0.04 5.26 
0.85 0.04 
0.3 0.6 
0.58 0.45 
4. 7 + 2.11 
4 
5.8 ± 2.20 
5 
4.8_±2.11 
5 
5.7_±0.97 
5 
0.01 
0.93 
1. 3 
0.27 
0 
1.00 
63.7+2.l 
5 
69.6 + 1.8 
5 
64.1 + 2.5 
5 
71.8 ± 0.4 
5 
2.4 
0.14 
64.9 
0.000 1 
1.1 
0.30 
123.6 ± 5.9 
5 
145.4 � 12. 7 
5 
120.8 ± 9.8 
5 
173.2 _± 14.2 
5 
6.3 
0.02 
55.8 
0.0001 
9.5 
0.007 
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Summary statistics for the BAEP latencies are presented in Table 4, 
along with the results of the ANOVA comparisons for each of the four 
groups, The component latencies are slightly slower in the diabetics, 
However, the differences do not show significance. At wave v the dia-
betics are about 0, 2 msec slower than the nondiabetics ( o 06) p = . • The 
differences are small relative to the standard deviations, however the 
trend is consistent, Figure 4 illustrates the accumulation of diagnostic 
group latency differences over the interwave intervals from wave I to 
wave V, 
The BAEP amplitudes were measured as the height of each waveform 
from its right base up to its peak, This distance measure was converted 
to microvolt (uV) units using a calibration square wave pulse of known 
voltage that was summated in the same way as the scalp recorded responses, 
Swmnary statistics for the BAEP amplitudes are presented in Table 5. 
Amplitudes for waves I, III, and V were tested for group differences, 
Females tended to have slightly larger wave V amplitudes (p = 0.05), 
however, there was no significant diagnostic group difference (see 
Michalewski et !!l·, 1980) 
CTT for the BAEP was calculated by subtracting wave I latency from 
wave V latency (Starr, 1978; Starr & Achor, 1979; Salamy & McKean, 1976; 
Salamy� al., 1975), Summary statistics for the measure are presented 
in Table 6. Mean BAEP CTT for the diabetic group is about 0.2 msec long-
er than for the nondiabetics, just as for wave V latency (diabetic mean = 
4.2 msec, nondiabetic mean = 4.0 msec). The diagnostic group difference 
shows significance (p = 0.03), The slower CTT suggests that diabetes 
to affect the metabolic integrity of the brainstem audi­may have begun 
tory pathway. However, the absence of any difference in the overall 
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N 
DIABETICS: 
Female 
n 
Male 
n 
NONDIABETICS: 
Female 
n 
Male 
n 
DIAGNOSIS: 
F 
.£ 
SEX: 
F 
.£ 
DIAGNOSIS & SEX 
INTERACTION: 
F 
.E 
I 
1.43 + 0.13 
4 
1.49 .± o. 14 
5 
1.51 .± 0.09 
5 
1.47 .± 0.03 
5 
0.4 
0.56 
0.03 
0.87 
1.2 
0.29 
Table 4 
Brainstem Auditory Evoked Potential Latencies 
(msec) 
II III IV V 
2.59 + 0.11 3.71+0.13 4.90 + 0.20 5.59 + 0.33 
4 4 3 4 
2.63 .± 0.10 3.66 .± 0.11 4.65 + 0.05 5.67 .± 0.06 
5 5 3 5 
2.51 + 0.21 3.64 .± 0.30 4.60 + 0.13 5 .40 .± o. 11 
4 5 4 5 
2.52 .± 0.04 3.60 .± 0.16 4.70 + 0.25 5.50 .± 0.22 
5 5 5 5 
2.6 0.5 1. 2 4.1 
0.13 0.49 0.30 0.06 
0.2 0.2 0.4 1. 3 
0.68 0.64 0.52 0.28 
0.1 0.04 2.6 0 
o. 77 0.84 0.14 1,00 
VI VII 
6.91 + 0.17 8.63 + 0.18 
4 3 
7.31 + 0.35 8.95 .± 0.65 
4 5 
6.48 .± 0.45 8.64 + 0.32 
5 4 
7.17 .± 0.43 8.58 .± 0.25 
5 2 
0.4 0.7 
0.56 0.41 
4.1 0.7 
0.06 0.42 
0.04 0.2 
0.85 0.66 
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N 
DIABETICS: 
Female 
n 
Male 
n 
NONDIABETICS: 
Female 
n 
Male 
n 
DIAGNOSIS: 
SEX: 
F 
.£ 
F 
.£ 
DIAGNOSIS & SEX 
INTERACTION: 
F 
.£ 
I 
Table 5 
Brainstem Auditory Evoked Potential Amplitudes 
(uV) 
I 
0.36+0.22 
4 
0.31 + 0.08 
5 
0,27 _± 0,06 
4 
0.26 _± 0.13 
4 
1.0 
0.33 
0.2 
0.67 
0.1 
o. 77 
III 
0.28+0.13 
4 
0.28 .± 0.13 
5 
0.18 .± 0.007 
3 
0,28 .± 0.12 
4 
0.5 
0.49 
0.5 
0.48 
o. 7 
0.42 
V 
0,58 + 0.15 
4 
0.50 + 0.12 
5 
o. 70 + 0.21 
4 
0,48 .± 0.12 
4 
0.4 
0.52 
4.5 
0.05 
1.1 
0.32 
Ratio of 
V to I 
2.79 + 3.14 
4 
1,67 _± 0.65 
5 
2.71+1.18 
4 
2.19 + 1. 30 
4 
0.1 
o. 76 
1.0 
0.34 
0.1 
o. 72 
co 
N Table 6 
Central Transmission Times and Median Nerve Conduction Velocities 
DIABETICS: 
Female 
n 
Male 
n 
NONDIABETICS: 
Female 
n 
Male 
n 
DIAGNOSIS: 
F 
£ 
SEX: 
F 
£ 
DIAGNISOS & SEX 
INTERACTION: 
F 
£ 
BAEP SEP SEP Median 
I to V P9 to Pl4 Pl4 to Nl8 Nerve CV 
(msec) (msec) (msec) (m/sec) 
4.16 + 0.33 4. 78 _± 1.08 4.52 _± 0.65 49.8 _± 5.3 
4 4 5 5 
4.18 _± 0.10 4.90 _± 0.22 4.74 _± 0.61 55.9 _± 5.7 
5 4 5 3 
3.89 _± 0.12 3.80 + 0.35 5.38 + 0.44 59.3 + 5.8 
5 5 5 4 
4.03 _± 0.21 4.31 _± 0.21 5.82 _± 0.99 59.3 .± 4.0 
5 4 5 5 
5.5 8.1 9.6 7 .4 
0.03 0.01 0.007 0,02 
1. 1 2.0 1. 1 2.3 
0.32 0.18 0.31 0.15 
0.2 0.2 0.1 1. 2 
0.66 0.69 0.73 0.29 
appearance of the BAEP suggests that no morphological changes have 
occurred. 
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The median nerve CV measure was calculated by dividing the distance 
between the stimulating electrodes and the recording electrode by the 
latency of the nerve volley, recorded at the elbow (see Fig. 1) (Cracco 
� �., 19 7 9). The latency of the nerve volley was taken as the peak 
of the initial positivity, which corresponds to the onset of the negative 
component. Some of the median nerve volley recordings, while sufficient 
for latency determinations, are of poor quality because the recording 
electrode was not always directly over the nerve fiber. Use of a mobile 
recording probe would have permitted more precise location of the nerve. 
The median nerve CV results are summarized in Table 6 along with the 
CTTs. As expected, median nerve CV was significantly slower among the 
diabetics, indicating the presence of peripheral neuropathy (p = 0.02) 
(diabetic mean = 52.8, nondiabetic mean = 59,3). The diagnostic group 
means differ by about 6.5 m/sec. 
Summary statistics for SEP latencies are presented in Table 7A 
along with analysis of variance results. The diabetics have slightly 
longer latencies for the first three components with only the Pl4 differ
ence showing significance. However, the Pl4 diagnostic group difference 
is relatively dramatic (p = 0.003) (diabetic mean = 14 .8, nondiabetic 
mean = 13. 9 ). Pl4 is delayed by about 0.9 msec in the diabetic group. 
This difference disappears at Nl8, suggesting a reduction in terminal 
branching of the thalamocortical radiations (Desmedt & Cheron, 1980c), 
(diabetic mean = 19.3 msec, nondiabetic mean = 1 9.4 msec). Figure 5 il
lustrates the changing relationship of the diagnostic group latency 
differences over the interNave intervals from P9 to P22. 
0 
<'"I 
DIABETICS: 
Female 
n 
Male 
n 
NONDIABETICS: 
Female 
n 
Male 
n 
DIAGNOSIS: 
SEX: 
F 
.E 
F 
.E 
DIAGNOSIS & SEX 
INTERACTION: 
F 
.E 
P9 
9. 71 + o. 94 
4 
9.90+0.74 
4 
9.14 ± 0.73 
5 
10.18 ± 0.33 
4 
0.5 
0.51 
3.1 
0, 10 
1.6 
0.23 
Table 7A 
Somatosensory Evoked Potential Latencies 
(msec) 
Pl2k Pl4 
12.23 + 0.42 14.52 + 0.23 
4 s 
12.40 .:!: 0.98 14.92 .:!: 0.67 
3 5 
11.15 +0.83 12.94 .:!: 0.83 
4 5 
12.82 ± 0.58 14.64 .:!: 0,43 
5 
12.5 
0.003 
15. 9 
0.001 
6.1 
0,03 
* Incorrectly designated as Pl2 rather than Pll and Pl). 
Nl8 P22 
19.04 + 0.72 22. 72 .:!: 0.93 
s 5 
19.66 .:!: 1.23 23.25 + 1.03 
5 4 
18.32 .:!: 0.90 22,63 + 0,59 
5 4 
20.46 .:!: 1.10 22. 95 .:!: 1.06 
5 2 
0.01 0,2 
0.93 0.65 
9.4 1. 0 
0.007 0.34 
2.8 0 
0.11 1.00 
..... 
(') 
14-
12-
IO-
18-
t, 6-
4-
2-
Bar Graph of Cumulative Somatosensory Evoked Potential 
Interwave Transmission Times 
........i-. .-+-
rfi rt .-+--
rt- r+ 
rhrt 
0 a a I I I I I I I I I I I I I I I I I I I 
D N D N D N D N O N  
wove P9 segmenl segment Sl!l;Plent sec,nent 
latency P9 to Pl2 P9 to Pl4 P9 to MS P9 to P22 
Figure 5: Display of the accumulation of interwave transmission time differences over the en ti re SEP. The 
diagnostic group difference reaches significance only for the P9 to Pl4 segment in this figure. (The P14 to 
Nl8 segment is significantly shorter among the diabetic group, however this segment is hidden in the P9 to 
Nl8 segment depicted here,) 
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The difference in P9 latencies is unexpectedly small given the 
difference in median nerve CV between the two groups (see Table 6). If 
P9 originated at the level of the axilla (Desmedt & Cheron, 1980b), the 
median nerve CV difference would be expected to produce about a 0.9 msec 
delay in P9 latency in the diabetics, given an arm length of 45 cm. A 
group arm length difference may have been responsible for the 0.7 msec 
discrepancy (0.9(expected) - 0.2(actual) = 0.7). The nondiabetic males 
tended to be taller and heavier than the diabetic males while the female 
participants were more homogeneous in height and weight. The differ-
ences are reflected in the diagnostic group means given in Table 3. 
This height discrepancy may have influenced the SEP latencies. Since 
height is related to arm length, there is reason to expect that height 
may have biased the SEP latencies in the taller nondiabetics, thereby 
disguising the influence of diabetes on the SEP latencies of the shorter 
diabetics. As an attempt to account for the height influence, analyses 
of co-variance were repeated on the SEP latencies with height covaried 
out (see Table 7B). Since the females were homogeneous with respect to 
height, it is interesting to note the larger difference in P9 latencies 
between the two groups of females. The P9 difference (0. 7 msec) is more 
congruent with the median nerve CV findings. 
Summary statistics for SEP amplitudes are presented in Table 8. 
SEP amplitudes were calculated as they were for the BAEP amplitudes, with 
the exception of Nl8. Nl8 amplitude represents the vertical displacement 
from the lowest point of Nl8 up to the highest point of P22. The diabe­
tics have dramatically lower amplitudes for Pl4 and Nl8 (p = 0.004 and p 
0.007, respectively). These measures of the descending (Pl4) and ascen­
ding (Nl8) limbs of the Nl8 wave are probably closely related. Thus, the 
(") 
(") 
Table 7B 
Somatosensory Evoked Potential Latencies with Height Covaried Out 
(msec) 
P9 Pl4 Nl8 P22 
HEIGHT: 
F 12, 1 8, l 12,8 1. 8 
.E 0,003 0,01 0,002 0,21 
--
DIAGNOSIS: 
F 0,8 10,9 0,1 0,2 
.E 0,47 0,001 0,88 0,81 
SEX: 
F 0,9 0,3 0 0,01 
.E 0,36 0, S 7 0,95 0,94 
DIAGNOSIS & SEX 
INTERACTION: 
F 1, 1 s.o 1,8 0,1 
.E 0,31 0,04 0,20 0,76 
..j­
C") 
DIABETIC: 
Female 
n 
Male 
n 
NONDIABETIC: 
Female 
n 
Male 
n 
DIAGNOSIS: 
SEX: 
F 
.£ 
F 
.£ 
DIAGNOSIS & SEX 
INTERACT ION: 
F 
.£ 
Table 8 
Somatosensory Evoked Potential Amplitudes 
(uV) 
P9 Pl2 P14 
0.21 + 0.30 0.05 ± 0.01 3.41 ± 1. 17 
2 3 5 
0.22 ± 0.13 0.23 + 0.25 2.83 ± 0.83 
4 3 5 
0.21 + 0.17 0.32+0.15 4.85 ± 0.41 
4 4 5 
0.36 ± 0.05 0.10 + 0.08 4.31 + 1.23 
4 5 5 
0.6 11.4 
0.44 0.004 
0.9 1. 7 
0.38 0.21 
1.0 0 
0.35 1.0 
Nl8 
2.81 ± 0.77 
5 
2.03 ± 0.70 
4 
4.20 + 2.00 
4 
5.24 ± 0.45 
2 
10.7 
0.007 
0.3 
0.62 
1. 7 
0.23 
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Pl4 and Nl8 amplitude measures may actually reflect the same thing: a 
relatively smaller negative displacement of the lowest point of Nl8 among 
the diabetics. No other SEP amplitudes showed any significant group 
difference. 
Summary statistics for two SEP CTT measures are presented in Table 
6. The P9 to Pl4 measure is the conduction time from the peak of the 
first component of the early SEP up to the peak of the most prominent 
early positivity. The Pl4 to Nl8 measure is the conduction time from 
the most prominent early positivity up to the most prominent early nega-
tivity, corresponding to the brainstem-to-thalamocortical transition 
(Desmedt & Cheron, 1980b). Like the BAEP CTT, both of the SEP CTT mea-
sures show a significant diagnostic group difference. However, the 
directions of the two SEP CTTs are opposite. The diabetics have a longer 
CTT from P9 to Pl4 while the Pl4 to Nl8 segment is shorter in this group. 
Recall that the diabetics also had significantly reduced amplitudes on 
the descending and ascending limbs of Nl8. As with the smaller Pl4 and 
Nl8 amplitudes among the diabetics, the shorter Pl4 to Nl8 segment might 
also reflect a reduction in terminal branching of the thalamocortical 
radiations. 
A plot of each participants' BAEP CTT versus his/her SEP CTT (P9 to 
Pl4) shows a strong linear trend (see Fig. 6). This relationship implies 
that the longer CTTs observed in the diabetics occur together in both 
modalities and reflect a mild but pervasive metabolic influence of dia­
betes throughout the CNS. The plot reflects to a degree the same find­
ings as the analyses of variance tests for the CTTs. However, correla­
tions of the BAEP CTT and the SEP CTT, by diagnostic classification, 
reveal additional information about the relationship. There is a 

significant correlation between the two CTTs among the diabetics (r = 
0 , 86 , p = 0, 01), but not among the nondiabetics (r = 0.31, p = 0,42), 
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The degree of peripheral nerve diahetic neuropathy has been shown 
repeatedly to be inversely related to the degree of glycemic control 
(Greene��., 1981; Porte� al., 198 1; Horowitz & Ginsberg-Fellner, 
1979; Pirart, 1978; Skyler� al,, 1978; Ward��., 1971; Gregerson, 
1967). Better blood glucose control is associated with less peripheral 
neuropathy, Looking at Fig, 6, it appears that the large BAEP CTT 
SEP CTT correlation among the diabetics is a result of the greater dis­
persion of the diabetics along the regression line, This finding sug­
gests that not all the diabetics show a diagnostic effect, Furthermore, 
the dispersion may be related to the degree of glycemic control, as it 
is at the peripheral level, The demonstration of a relationship between 
CTTs and glycemic abnormality would verify that longer CTTs in diabetics 
are a result of glycemic abnormality and validate the use of EPs to 
diagnose CNS diabetic neuropathy. 
Discussion 
The diabetic group in this study evidenced significant slowing of 
median nerve conduction velocity, indicative of peripheral nerve diabe-
tic neuropathy. Furthermore, the three CTT measures reported in this 
study each showed a significant diagnostic group difference, suggesting 
a detrimental effect of diabetes on CNS function. However, the direction 
of the diagnostic group difference was not the same for the three CTT 
measures. The BAEP CTT (wave I to wave V) and the SEP CTT (P9 to Pl4), 
both of early brainstem origin, were significantly longer in the diabe-
tic group,probably reflecting slowed central conduction. The SEP CTT 
(Pl4 to Nl8), of midbrain origin, was significantly shorter in the dia-
betics, possibly reflecting a reduction in thalamocortical radiations 
(Desmedt & Cheron, 1980b). More definitive statements of the meaning of 
t hese findings await the resolution of measurement problems and a better 
knowledge of the neural origins of the EP waveforms. 
The group means for the SEP CTTs suggest a serious question concern-
ing accurate designation of the Pl4 component in the nondiabetics. As 
an extension of the nomenclature, the anticipated CTT from P9 to Pl4 is 
about 5 msec. The anticipated CTT from Pl4 to Nl8 is about 4 msec. 
These values appear essentially reversed in the nondiabetics, with P9 to 
Pl4 being about 4 msec, and Pl4 to Nl8 being over 5 msec (Table 6). One 
could argue that the component designated as Pl4 in the nondiabetics is 
actually Pl3 and that the diagnostic group difference in the CTTs merely 
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reflects the "misdesigna tion". Desmed t & Cheron (1980b) have pointed 
out how Pl3 can be incorrectly designated as Pl4 (see Fig. 2) when Pl3 
is inordinately large and predominates over Pl4. To further exacerbate 
the uncertainty a small PlS is sometimes present on the descending limb 
of Pl4, mimicking the Pl3-Pl4 condition in the lower SEP of Fig. 2 
(Desmedt & Cheron, 1980b; Starr, 1978; Greenberg et al., 1977). It is 
possible that the naming of PlS is actually an error of misinterpreting 
the Pl3 and Pl4 waves in taller individuals. 
The issue of correct designation is much more complex than just mere 
variation in wave morphology. Given a CV of 60 m/sec, an average of 
about 0. 17 msec is required for each cm of conduction distance over the 
median nerve. Desmedt & Cheron (1980c) have attributed differences of 
as much as 2 msec in P9 onset latency to intrasubject differences in arm 
length. Thus, it is not unreasonable that the P9 wave could have a peak 
latency of as low as 7 msec or as high as 1 1 msec among normal indivi-. 
duals with identical median nerve CVs, because of inter-individual 
differences in the length of the nerve pathway. The polarity-latency 
combination nomenclature is only a representation of mean peak latencies 
from large samples where height is ignored as a factor. It is unreliable 
as a rigid guideline for designation of SEP components. 
When comparing SEPs from a group that is heterogeneous with respect 
to height, the largest component of height-related variation in peak 
latencies arises from the longest segment of the stimulated pathway, 
that is, from the stimulation site up to the axilla (vicinity of P9 ori­
gin). However, it is important to realize that this component is not 
the only component of height related variation in peak latencies. It is 
reasonable to assume that height is related to body size and that it 
tends to be distributed proportionally over th �· · 1 e enLire vertica axis. 
Therefore, it is expected that taller individuals would tend to have a 
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greater chest girth also. 's · th h 1 " suming at one- a f of chest girth closely 
corresponds to the nerve pathway length from the axilla to the point of 
spinal entry (onset of Pll), it is expected that taller individuals 
should have a greater conduction·time between the peaks ot pg and Pll. 
However, this component of height related variation in peak latencies is 
smaller than that of the first segment (stimulus onset up to peak of P9) 
because the nerve segment is shorter. An analogous argument applies for 
the remaining peak-to-peak segments of the SEP. The two major points can 
be generally stated as follows: 1) not only is height directly related 
to SEP latencies, but also it is related to the interpeak latencies. 
Thus, the height effect cannot be subtracted as an overall constant from 
each peak latency. However, 2) the height related variation in interpeak 
latencies should be proportional to the length of the nerve segment be-
tween the two peaks involved. Thus, the height factor should be less 
significant for shorter caudal segments of the nerve pathway than it is 
for longer rostral segments. These relationships are problematic when 
the SEP is used to determine impaired CNS function because the putative 
disease effect will be similar to the height effect. Therefore, the 
height effect must be accurately assessed in order to draw sound conclu­
sions concerning group differE:nces in peak latencies and interpeak dis-
tances, as they reflect neural processes. Clearly, the covariance ap-
proach employed in this study was effective in dealing with height 
related variation in the SEPs. However, the covariance approach was 
limited in that the height related variation may have hampered correct 
designation of the component peaks. Where peaks P9, Pll, and Pl3 are 
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involved, the height related variation is best controlled by recording 
the nerve volley at the axilla (origin of P9) and over cervical verte­
brae 6 and 7 (onset of Pll) (Desmedt & Cheron, 1980b). These recordings 
allow accurate designation of the scalp recorded P9 and Pll by essenti­
ally having recorded the potential from two points that give the same 
latencies as the scalp recorded SEP. Such a tight designation of P9 and 
Pll reduces the difficulty in accurately designting Pl3 and Pl4 thereby 
making the differences induced by any disease factor more detectable. 
In this study, the scalp recorded SEPs were extensively evaluated to 
insure accurate designation of the components. Since axilla and neck EPs 
were not recorded, the scalp SEP peaks were designated based on their 
overall appearance and to a degree, on the anticipated nominative peak 
latencies. Knowledge of the diagnostic group classification was not con-
sidered during the initial scoring. The data were then entered into the 
computer for calculation of summary statistics. Outlying observations 
were then checked for validity. Finally, the SEPs were rescored a second 
time from scratch with any scoring differences thoroughly reconsidered 
by Dr. Harkins and myself. In light of the new information concerning 
Pll and P13 (rather than Pl2), the SEPs will be rescored a third time 
prior to any further publication. 
More research needs to be done to clarify the components of the SEP, 
their origins, and factors influencing their appearance. Unlike the BAEP, 
it is not possible to clearly interpret the SEP findings presented here 
until such information is available. Nonetheless, there are some notable 
consistencies. The BAEP CTT, PCV, and SEP CTT (P9 to Pl4) for the dia-
betic group are all in the expected direction. Thus, it appears that, 
d. b t· conduction times tend to be longer throug
hout the 
among ia e ics, 
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nervous system. These findings are analogous to age differences obser­
ved by Desmedt & Cheron (1980 a & c) in a group of octogenarians. Gupta 
and Dorfman (1981) have observed a similar trend in a heterogeneous 
group of diabetics, except they found no differences at the supraspinal 
level. However, their technique involved estimation of several para­
meters that would be affected by diabetic neuropathy. It is not clear 
whether assumptions involved in these estimations remain valid in cases 
of diabetic neuropathy (see Dorfman, 1977 for technique of estimating 
conduction time based on the F-wave motorneuron backfiring phenomenon). 
Bibliography 
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